Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Investor Relations

View Investor Relations

Latest News

Ligand Reports Fourth Quarter and Full Year 2018 Financial Results

Read More

Ligand Announces OmniAb® Partnership with Genagon Therapeutics

Read More

Ligand Announces Investment in Dianomi Therapeutics

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range